drugset / Trial / NCT01582113

Cognizin Citicoline Dosing in a Healthy Adolescent Male Population

NCT01582113

Phase 0 Completed 84 enrolled Deborah Yurgelun-Todd
RandomizedParallel-groupTriple-blindTreatment

Summary

To determine the functional effects of Citicoline, a natural supplement, when administered for a duration of four weeks (28 days) to non-psychiatric adolescent male participants. The investigators hypothesize that citicoline will provide cognitive benefits to this population after 28 days of supplementation.

Timeline

Start
2012-06
Primary completion
2017-05-24
Completion
2017-05-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Citicoline Other / unclassified 250 mg Oral
Subject Citicoline Other / unclassified 500 mg Oral

Indications

No indication recorded.